Protocol for recombinant expression in E. coli and purification of iBoost vaccine proteins using immobilized metal affinity chromatography
STAR Protocols · 2026-06 · 7 (2) · 104572
DOI: 10.1016/j.xpro.2026.104572 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift STAR Protocols, 2026-06. Verfasst von Elisabeth J M Huijbers und 9 weiteren Autor:innen. Beteiligte Einrichtung: Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands; CimCure BV, 1066…. Hauptthemen laut MEDLINE: Chromatography, Affinity, Escherichia coli, Recombinant Proteins. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, European Commission Marie Sklodowska-Curie Actions, KWF Kankerbestrijding.
Abstract (Originalsprache)
The iBoost vaccine technology enables the induction of a humoral immune response against self- and low-immunogenic antigens through fusion of the antigen to an immunogenic bacterial carrier. Here, we present a protocol for recombinant expression in E. coli and purification of iBoost vaccine proteins using immobilized metal affinity chromatography (IMAC). In addition, we describe procedures to evaluate antigen-specific immune responses in mice. This protocol can be readily adapted for the generation and testing of vaccines against a broad range of antigens. For complete details on the use and execution of this protocol, please refer to Huijbers et al., Van Beijnum et al., and Van Loon et al.1,2,3,4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands; CimCure BV, 1066 CX Amsterdam, the Netherlands. Electronic address: e.huijbers@amsterd…
- Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
- Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands; CimCure BV, 1066 CX Amsterdam, the Netherlands.
- Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands; CimCure BV, 1066 CX Amsterdam, the Netherlands. Electronic address: a.griffioen@amster…
Förderung
- European Commission
- European Commission Marie Sklodowska-Curie Actions
- KWF Kankerbestrijding
- Health~Holland
Zitieren
APA
Huijbers, E. J. M., van Beijnum, J. R., Koetsier, J., Wachholz, G. E., Kemper, P. C. J., Myburgh, L., Meister, S., van Loon, K., Cassee, M. A., & Griffioen, A. W. (2026). Protocol for recombinant expression in E. coli and purification of iBoost vaccine proteins using immobilized metal affinity chromatography. STAR Protocols, 7(2), 104572. https://doi.org/10.1016/j.xpro.2026.104572
Vancouver
Huijbers EJM, van Beijnum JR, Koetsier J, Wachholz GE, Kemper PCJ, Myburgh L, et al. Protocol for recombinant expression in E. coli and purification of iBoost vaccine proteins using immobilized metal affinity chromatography. STAR Protocols. 2026;7(2):104572. doi:10.1016/j.xpro.2026.104572
BibTeX
@article{Huijbers2026,
author = {Huijbers, Elisabeth J M and van Beijnum, Judy R and Koetsier, Joost and Wachholz, Gabriela E and Kemper, Peter C J and Myburgh, Lauren and Meister, Steijn and van Loon, Karlijn and Cassee, Mattie A and Griffioen, Arjan W},
title = {Protocol for recombinant expression in E. coli and purification of iBoost vaccine proteins using immobilized metal affinity chromatography},
journal = {STAR Protocols},
year = {2026},
volume = {7},
number = {2},
pages = {104572},
doi = {10.1016/j.xpro.2026.104572}
}
EUVIMED